Epithelial-Mesenchymal Transition, human (Scheel, 2011)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
RARG | hg38_v1_chr12_-_53220229_53220272, hg38_v1_chr12_-_53220377_53220413 | -0.51 | 1.9e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr12_-_91182652 Show fit | 2.86 |
ENST00000552145.5
ENST00000546745.5 |
decorin |
|
chr3_+_45026296 Show fit | 2.64 |
ENST00000296130.5
|
C-type lectin domain family 3 member B |
|
chr1_+_78490966 Show fit | 2.27 |
ENST00000370757.8
ENST00000370756.3 |
prostaglandin F receptor |
|
chr15_+_32717994 Show fit | 2.08 |
ENST00000560677.5
ENST00000560830.1 ENST00000651154.1 |
gremlin 1, DAN family BMP antagonist |
|
chr17_-_55732074 Show fit | 2.03 |
ENST00000575734.5
|
transmembrane protein 100 |
|
chr8_-_107497909 Show fit | 1.88 |
ENST00000517746.6
|
angiopoietin 1 |
|
chr15_+_32718476 Show fit | 1.87 |
ENST00000652365.1
|
gremlin 1, DAN family BMP antagonist |
|
chr8_-_107498041 Show fit | 1.87 |
ENST00000297450.7
|
angiopoietin 1 |
|
chr8_+_96584920 Show fit | 1.69 |
ENST00000521590.5
|
syndecan 2 |
|
chr1_+_163069353 Show fit | 1.61 |
ENST00000531057.5
ENST00000527809.5 ENST00000367908.8 ENST00000367909.11 |
regulator of G protein signaling 4 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 7.3 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
1.3 | 3.9 | GO:1900154 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
1.2 | 3.7 | GO:0035691 | macrophage migration inhibitory factor signaling pathway(GO:0035691) |
0.5 | 3.2 | GO:2000230 | negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
0.2 | 2.8 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.9 | 2.6 | GO:0035638 | patched ligand maturation(GO:0007225) signal maturation(GO:0035638) |
0.0 | 2.6 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.8 | 2.3 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
0.2 | 2.3 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 2.2 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 8.1 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.0 | 3.1 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 3.0 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 2.8 | GO:0031430 | M band(GO:0031430) |
0.4 | 2.5 | GO:0001652 | granular component(GO:0001652) |
0.1 | 2.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 2.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 2.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 2.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 2.1 | GO:0005901 | caveola(GO:0005901) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 8.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 5.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.4 | 5.0 | GO:0036122 | BMP binding(GO:0036122) |
0.3 | 3.2 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 3.0 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 2.8 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 2.4 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.8 | 2.3 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
0.3 | 2.3 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.3 | 2.3 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 7.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 5.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 5.4 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 4.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 4.1 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 2.9 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 2.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 2.1 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 2.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 1.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 7.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 4.9 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 3.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 3.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.3 | 3.3 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 2.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.2 | 2.3 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 2.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.9 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 1.6 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |